Luthringer Remy
CEO at NERV
- Sold, on record
- $536k
- Dollars the filings state
- Form 4 sales
- 6
- Latest May 2, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NERVMinerva Neurosciences, Inc.CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NERVUnusualFeb 6, 2017 2017
Sold 34,281 shares at $11.02 ($378k)
Luthringer Remy, President & CEO
Sold 100% of holdings ($378k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale NERVPlan not statedDec 14, 2017 +311 days
Sold 2,194 shares at $5.85 ($13k)
Luthringer Remy, CEO
Sold 11.7% of holdings ($110k position)16,556 shares leftFiling
- 3 Form 4 sale NERVPlan not statedDec 17, 2018 +368 days
Sold 2,604 shares at $7.46 ($19k)
Luthringer Remy, CEO
Sold 7.4% of holdings ($263k position)32,702 shares leftFiling
- 4 Form 4 sale NERVPlan not statedDec 17, 2019 +365 days
Sold 2,412 shares at $7.10 ($17k)
Luthringer Remy, CEO
Sold 4.7% of holdings ($365k position)49,040 shares leftFiling
- 5 Form 4 sale NERVPlan not statedDec 16, 2020 +365 days
Sold 1,300 shares at $2.64 ($3k)
Luthringer Remy, CEO
Sold 1.9% of holdings ($179k position)66,490 shares leftFiling
- 6 Form 4 sale NERVUnusualMay 2, 2023 +867 days
Sold 27,394 shares at $3.84 ($105k)
Luthringer Remy, CEO
No 10b5-1 planSold 28.4% of holdings ($370k position)68,994 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | May 2, 2023 | NERV | CEO | Form 4 sale | 27,394 | $105k | 28.4% | Unusual | SEC |
| Dec 16, 2020 | Dec 16, 2020 | NERV | CEO | Form 4 sale | 1,300 | $3k | 1.9% | Plan not stated | SEC |
| Dec 17, 2019 | Dec 17, 2019 | NERV | CEO | Form 4 sale | 2,412 | $17k | 4.7% | Plan not stated | SEC |
| Dec 17, 2018 | Dec 18, 2018 | NERV | CEO | Form 4 sale | 2,604 | $19k | 7.4% | Plan not stated | SEC |
| Dec 14, 2017 | Dec 15, 2017 | NERV | CEO | Form 4 sale | 2,194 | $13k | 11.7% | Plan not stated | SEC |
| Feb 6, 2017 | Feb 7, 2017 | NERV | President & CEO | Form 4 sale | 34,281 | $378k | 100.0% | Unusual | SEC |